These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 33022373)

  • 1. MicroRNAs: roles in cardiovascular development and disease.
    Kalayinia S; Arjmand F; Maleki M; Malakootian M; Singh CP
    Cardiovasc Pathol; 2021; 50():107296. PubMed ID: 33022373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crafting a Blueprint for MicroRNA in Cardiovascular Diseases (CVDs).
    Khan SU; Saeed S; Sheikh AN; Arbi FM; Shahzad A; Faryal U; Lu K
    Curr Probl Cardiol; 2023 Dec; 48(12):102010. PubMed ID: 37544621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Molecules with Big Impacts on Cardiovascular Diseases.
    Mirzadeh Azad F; Arabian M; Maleki M; Malakootian M
    Biochem Genet; 2020 Jun; 58(3):359-383. PubMed ID: 31997044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA in cardiovascular biology and disease.
    Wojciechowska A; Braniewska A; Kozar-Kamińska K
    Adv Clin Exp Med; 2017 Aug; 26(5):865-874. PubMed ID: 29068585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA Signature and Cardiovascular Dysfunction.
    Arunachalam G; Upadhyay R; Ding H; Triggle CR
    J Cardiovasc Pharmacol; 2015 May; 65(5):419-29. PubMed ID: 25384197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.
    Hang P; Guo J; Sun C; Du Z
    Curr Drug Targets; 2017; 18(4):463-472. PubMed ID: 26926467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of miRNAs on the Pathophysiology of Cardiovascular Diseases.
    Silva DCPD; Carneiro FD; Almeida KC; Fernandes-Santos C
    Arq Bras Cardiol; 2018 Nov; 111(5):738-746. PubMed ID: 30484515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNAs in cardiovascular diseases: current knowledge and the road ahead.
    Condorelli G; Latronico MV; Cavarretta E
    J Am Coll Cardiol; 2014 Jun; 63(21):2177-87. PubMed ID: 24583309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A MicroRNA Perspective on Cardiovascular Development and Diseases: An Update.
    Islas JF; Moreno-Cuevas JE
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30018214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs: role in cardiovascular biology and disease.
    Zhang C
    Clin Sci (Lond); 2008 Jun; 114(12):699-706. PubMed ID: 18474027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA and Cardiovascular Diseases.
    Çakmak HA; Demir M
    Balkan Med J; 2020 Feb; 37(2):60-71. PubMed ID: 32018347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in heart development.
    Espinoza-Lewis RA; Wang DZ
    Curr Top Dev Biol; 2012; 100():279-317. PubMed ID: 22449848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNAs in Heart Development and Disease.
    Lozano-Velasco E; Inácio JM; Sousa I; Guimarães AR; Franco D; Moura G; Belo JA
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-30 and 145 as Targets for the Treatment of Cardiovascular Diseases: Therapeutic Feasibility and Challenges.
    Tolouei SEL; Curi TZ; Klider LM; Junior AG
    Curr Pharm Des; 2021; 27(37):3858-3870. PubMed ID: 33308116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs Mediate Beneficial Effects of Exercise in Heart.
    Bei Y; Tao L; Cretoiu D; Cretoiu SM; Xiao J
    Adv Exp Med Biol; 2017; 1000():261-280. PubMed ID: 29098626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA therapeutics in cardiovascular disease models.
    Dangwal S; Thum T
    Annu Rev Pharmacol Toxicol; 2014; 54():185-203. PubMed ID: 24111539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating exosomal miRNAs in cardiovascular disease pathogenesis: New emerging hopes.
    Aghabozorgi AS; Ahangari N; Eftekhaari TE; Torbati PN; Bahiraee A; Ebrahimi R; Pasdar A
    J Cell Physiol; 2019 Dec; 234(12):21796-21809. PubMed ID: 31273798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.
    Zhou SS; Jin JP; Wang JQ; Zhang ZG; Freedman JH; Zheng Y; Cai L
    Acta Pharmacol Sin; 2018 Jul; 39(7):1073-1084. PubMed ID: 29877320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs and the heart: small things do matter.
    Papoutsidakis N; Deftereos S; Kaoukis A; Bouras G; Giannopoulos G; Theodorakis A; Angelidis C; Hatzis G; Stefanadis C
    Curr Top Med Chem; 2013; 13(2):216-30. PubMed ID: 23470079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review regulatory principles of non-coding RNAs in cardiovascular diseases.
    Li Y; Huo C; Pan T; Li L; Jin X; Lin X; Chen J; Zhang J; Guo Z; Xu J; Li X
    Brief Bioinform; 2019 Jan; 20(1):66-76. PubMed ID: 28968629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.